Stay updated on Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, representing a new published version of the page.
    Difference
    0.0%
    Check dated 2026-05-16T10:11:06.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The Taiwan site location was updated to Taoyuan County, Taiwan, replacing the previous Taoyuan entry to reflect the correct administrative region for that study site.
    Difference
    0.0%
    Check dated 2026-05-02T09:26:33.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page footer revision/version label was updated from v3.5.2 to v3.5.3, reflecting a platform/version change rather than a change to the NCT study information.
    Difference
    0.0%
    Check dated 2026-04-25T05:16:55.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Updated the collaborator name to Ono Pharmaceutical Co., Ltd. and revised the document version from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T23:59:25.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Publications section updated to include Bitar R, Salem R, Finn R, Greten TF, Goldberg SN, Chapiro J. Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma. Radiology. 2024 Nov;313(2):e232875. doi: 10.1148/radiol.232875.
    Difference
    0.0%
    Check dated 2026-04-10T19:34:09.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a term/resource and the Genetic and Rare Diseases Information Center as a resource, and updated the revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T01:12:54.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.